Fluticasone Propionate Aerosol, Metered
Product Images NDC 68788-8762

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 68788-8762). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fluticasone Propionate Chemical Structure (Fluticasonepropionatehfa Spl Graphic 01)

Chemical structure of fluticasone propionate showing its molecular framework, including rings and various functional groups such as hydroxyl, fluorine, and ester components as typical for the compound.*

FDA Label Image

Figure 1. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Inadequately Controlled On Bronchodilators Alone: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 1) (Fluticasonepropionatehfa Spl Graphic 02)

A line graph showing the percent change from baseline in FEV1 over 12 weeks and at endpoint. It compares placebo and Fluticasone Propionate HFA 88 mcg twice daily, with the latter showing higher improvement throughout the study period.*

FDA Label Image

Figure 2. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 2) (Fluticasonepropionatehfa Spl Graphic 03)

A line graph showing the percentage change from baseline in FEV1 over 13 weeks for four groups: placebo, and fluticasone propionate HFA at doses of 88 mcg, 220 mcg, and 440 mcg twice daily. The y-axis represents percent change, and the x-axis represents weeks. The higher doses show greater improvement compared to placebo.*

FDA Label Image

Figure 3. A 16-week Clinical Trial In Subjects Aged 12 Years And Older Requiring Chronic Oral Prednisone Therapy: Change In Maintenance Prednisone Dose (Fluticasonepropionatehfa Spl Graphic 04)

Bar graph depicting the percentage of subjects achieving 100% reduction in dose and the percentage of subjects with an increase in dose, comparing placebo, Fluticasone Propionate HFA 440 mcg twice daily, and Fluticasone Propionate HFA 880 mcg twice daily.*

FDA Label Image

Figure A (Fluticasonepropionatehfa Spl Graphic 05)

Illustration of an aerosol inhaler with labeled components including a metal canister, dark orange plastic actuator, dark orange mouthpiece, a counter on the side, and a peach-colored removable cap. The image shows the parts of the inhaler used for dosing fluticasone propionate respiratory medication.*

FDA Label Image

Figure B (Fluticasonepropionatehfa Spl Graphic 06)

An instructional illustration showing a person holding the mouthpiece cover of an inhaler in one hand and the inhaler unit in the other, with an arrow indicating the action of placing the cover onto the inhaler.*

FDA Label Image

Figure C (Fluticasonepropionatehfa Spl Graphic 07)

An instructional diagram showing a person inhaling from a pressurized metered-dose inhaler. The image highlights the spray being released from the inhaler's mouthpiece toward the person's mouth, illustrating the correct inhalation technique for a respiratory aerosol device.*

FDA Label Image

Figure D (Fluticasonepropionatehfa Spl Graphic 08)

An instructional illustration showing a hand holding a Fluticasone Propionate HFA metered-dose aerosol inhaler. The image demonstrates the proper hand position for use, with one finger pressing down on the top of the inhaler and the thumb supporting the base.*

FDA Label Image

Figure E (Fluticasonepropionatehfa Spl Graphic 09)

Instructional diagram showing proper positioning of a fluticasone propionate metered aerosol inhaler with the mouthpiece facing down. The illustration includes a hand holding the inhaler and labels pointing to the dark orange mouthpiece and the peach-colored cap placed nearby.*

FDA Label Image

Figure F (Fluticasonepropionatehfa Spl Graphic 10)

An instructional illustration showing a side profile of a person's face exhaling forcefully, accompanied by the text "Breathe out as much air as you can" with an arrow indicating the exhaled air flow. This image is likely to demonstrate a step in using a respiratory inhalation aerosol device.*

FDA Label Image

Figure G (Fluticasonepropionatehfa Spl Graphic 11)

An instructional illustration depicting the correct use of a metered-dose inhaler. It shows a person holding an inhaler near their mouth, pressing down the canister to release the medication while inhaling. The image includes the text "Push down and breathe in" with an arrow indicating the action.*

FDA Label Image

Figure H (Fluticasonepropionatehfa Spl Graphic 12)

An instructional diagram showing a person rinsing their mouth and spitting into a sink, with a glass of water visible nearby. The image illustrates a step commonly associated with inhalation medication use, such as after administering an aerosol inhaler dose.*

FDA Label Image

Figure I (Fluticasonepropionatehfa Spl Graphic 13)

An instructional diagram for the Fluticasone Propionate HFA aerosol inhaler showing two panels: one labeled 'Not blocked' illustrating proper aerosol spray release, and another labeled 'Blocked' demonstrating improper use with the inhaler spray obstructed. The image highlights correct inhaler technique by depicting airflow during actuation.*

FDA Label Image

Figure J (Fluticasonepropionatehfa Spl Graphic 14)

An instructional illustration showing a hand using a pointed object to press a button or access a small compartment on a device, likely related to the operation or maintenance of an inhaler device.*

FDA Label Image

Fluticasone Propionate Hfa Inh Aerosol 44mcg (Fluticasonepropionatehfa Spl Graphic 15)

Label for Fluticasone Propionate HFA Inhalation Aerosol 44 mcg from Preferred Pharmaceuticals Inc. The label includes dosage strength, generic reference to Flovent HFA, storage and usage instructions, and manufacturing information by Prasco Laboratories. It has sections titled 'Directions English' and 'Instrucciones Espanol' for bilingual usage directions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.